Literature DB >> 2828667

Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.

P R Donahue1, E A Hoover, G A Beltz, N Riedel, V M Hirsch, J Overbaugh, J I Mullins.   

Abstract

We report the first complete nucleotide sequence (8,440 base pairs) of a biologically active feline leukemia virus (FeLV), designated FeLV-61E (or F6A), and the molecular cloning, biological activity, and env-long terminal repeat (LTR) sequence of another FeLV isolate, FeLV-3281 (or F3A). F6A corresponds to the non-disease-specific common-form component of the immunodeficiency disease-inducing strain of FeLV, FeLV-FAIDS, and was isolated from tissue DNA of a cat following experimental transmission of naturally occurring feline acquired immunodeficiency syndrome. F3A clones were derived from a subgroup-A-virus-producing feline tumor cell line. Both are unusual relative to other molecularly cloned FeLVs studied to date in their ability to induce viremia in weanling (8-week-old) cats and in their failure to induce acute disease. The F6A provirus is organized into 5'-LTR-gag-pol-env-LTR-3' regions; the gag and pol open reading frames are separated by an amber codon, and env is in a different reading frame. The deduced extracellular glycoproteins of F6A, F3A, and the Glasgow-1 subgroup A isolate of FeLV (M. Stewart, M. Warnock, A. Wheeler, N. Wilkie, J. Mullins, D. Onions, and J. Neil, J. Virol. 58:825-834, 1986) are 98% homologous, despite having been isolated from naturally infected cats 6 to 13 years apart and from widely different geographic locations. As a group, their envelope gene sequences differ markedly from those of the disease-associated subgroup B and acutely pathogenic subgroup C viruses. Thus, F6A and F3A correspond to members of a highly conserved family and represent prototypes of the horizontally transmitted, minimally pathogenic FeLV present in all naturally occurring infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828667      PMCID: PMC253625          DOI: 10.1128/JVI.62.3.722-731.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Experimental transmission and pathogenesis of immunodeficiency syndrome in cats.

Authors:  E A Hoover; J I Mullins; S L Quackenbush; P W Gasper
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

2.  Restricted host range of a feline leukaemia virus.

Authors:  O Jarrett; H M Laird; D Hay
Journal:  Nature       Date:  1972-07-28       Impact factor: 49.962

3.  Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence.

Authors:  W D Hardy; Y Hirshaut; P Hess
Journal:  Bibl Haematol       Date:  1973

4.  Evolution of C-type viral genes: inheritance of exogenously acquired viral genes.

Authors:  R E Benveniste; G J Todaro
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

5.  Erythroid hypoplasia in cats inoculated with feline leukemia virus.

Authors:  E A Hoover; G J Kociba; W D Hardy; D S Yohn
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

6.  Determinants of the host range of feline leukaemia viruses.

Authors:  O Jarrett; H M Laird; D Hay
Journal:  J Gen Virol       Date:  1973-08       Impact factor: 3.891

7.  Infectious proviral DNA in human cells infected with transformation-defective type C viruses.

Authors:  M O Nicolson; F Hariri; H M Krempin; R M McAllister; R V Gilden
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

8.  An improved assay for feline leukaemia virus pseudotypes of murine sarcoma virus.

Authors:  P H Russell; O Jarrett
Journal:  J Gen Virol       Date:  1976-04       Impact factor: 3.891

9.  Evolution of type C viral genes: origin of feline leukemia virus.

Authors:  R E Benveniste; C J Sherr; G J Todaro
Journal:  Science       Date:  1975-11-28       Impact factor: 47.728

10.  Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses.

Authors:  P J Fischinger; C S Blevins; S Nomura
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

View more
  84 in total

1.  Molecular and phylogenetic analysis of SRS 19-6 murine leukemia virus.

Authors:  L M Bundy; H Fan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

Review 2.  The evolution, distribution and diversity of endogenous retroviruses.

Authors:  Robert Gifford; Michael Tristem
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

3.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses.

Authors:  J L Battini; J M Heard; O Danos
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.

Authors:  S Boomer; M Eiden; C C Burns; J Overbaugh
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  P R Donahue; S L Quackenbush; M V Gallo; C M deNoronha; J Overbaugh; E A Hoover; J I Mullins
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.

Authors:  Stig M R Jensen; Francis W Ruscetti; Alan Rein; Daniel C Bertolette; Carrie J Saucedo; Barry R O'Keefe; Kathryn S Jones
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  Feline leukemia virus immunity induced by whole inactivated virus vaccination.

Authors:  Andrea N Torres; Kevin P O'Halloran; Laurie J Larson; Ronald D Schultz; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2009-10-31       Impact factor: 2.046

9.  Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli.

Authors:  C Vink; K H van der Linden; R H Plasterk
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 10.  Advances in understanding molecular determinants in FeLV pathology.

Authors:  Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.